-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RR43+g1HTzsZ+QbPCqpxW3TXYWdczFN7GaraadHa4LFLzVeB8vLqe1IdCplENQB5 Qq2h7m0+h3S7KmDzrxz+xA== 0000950116-04-000399.txt : 20040205 0000950116-04-000399.hdr.sgml : 20040205 20040205102705 ACCESSION NUMBER: 0000950116-04-000399 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040205 GROUP MEMBERS: WEST PHARMACEUTICAL SERVICES INC. GROUP MEMBERS: WILMINGTON TRUST COMPANY GROUP MEMBERS: WILMINGTON TRUST CORPORATION GROUP MEMBERS: WILMINGTON TRUST FSB SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-17487 FILM NUMBER: 04568817 BUSINESS ADDRESS: STREET 1: 101 GORDON DR STREET 2: P O BOX 645 CITY: LIONVILLE STATE: PA ZIP: 19341-0645 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 101 GORDON DRIVE STREET 2: PO BOX 645 CITY: LIONVILLE STATE: PA ZIP: 19341-0645 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WILMINGTON TRUST CORP CENTRAL INDEX KEY: 0000872821 STANDARD INDUSTRIAL CLASSIFICATION: STATE COMMERCIAL BANKS [6022] IRS NUMBER: 510328154 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: RODNEY SQUARE NORTH STREET 2: 1100 NORTH MARKET ST CITY: WILMINGTON STATE: DE ZIP: 19890-0001 BUSINESS PHONE: 3026518378 MAIL ADDRESS: STREET 1: 1100 NORTH MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19890-0001 SC 13G/A 1 sc13g-a.txt SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2)* West Pharmaceutical Services Inc. ------------------------------------------------------------------------------- (Name of Issuer) Common Stock ------------------------------------------------------------------------------- (Title of Class of Securities) 955306-105 ------------------------------------------------------------------------------- (CUSIP Number) December 31, 2003 ------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [_] Rule 13d-(c) [_] Rule 13d-1(d) - ---------- * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 955306-105 - ------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Wilmington Trust Corporation - ------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [_] - ------------------------------------------------------------------------------- 3. SEC USE ONLY - ------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware corporation - ------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER 439,620 SHARES _____________________________________________________________ BENEFICIALLY 6. SHARED VOTING POWER 450,298 OWNED BY _____________________________________________________________ EACH 7. SOLE DISPOSITIVE POWER 439,620 REPORTING _____________________________________________________________ PERSON 8. SHARED DISPOSITIVE POWER 450,298 WITH: - ------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 889,918 - ------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] N/A - ------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.1% - ------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON HC - ------------------------------------------------------------------------------- CUSIP No. 955306-105 _______________________________________________________________________________ 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Wilmington Trust Company - ------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [_] - ------------------------------------------------------------------------------- 3. SEC USE ONLY - ------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware banking corporation - ------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER 439,620 SHARES _____________________________________________________________ BENEFICIALLY 6. SHARED VOTING POWER 445,400 OWNED BY _____________________________________________________________ EACH 7. SOLE DISPOSITIVE POWER 439,620 REPORTING _____________________________________________________________ PERSON 8. SHARED DISPOSITIVE POWER 445,400 WITH: - ------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 885,020 - ------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] N/A - ------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.1% - ------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* BK CUSIP No. 955306-105 - ------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Wilmington Trust FSB - ------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [_] - ------------------------------------------------------------------------------- 3. SEC USE ONLY - ------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Federal Savings Bank - ------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER 0 SHARES _____________________________________________________________ BENEFICIALLY 6. SHARED VOTING POWER 4,898 OWNED BY _____________________________________________________________ EACH 7. SOLE DISPOSITIVE POWER 0 REPORTING _____________________________________________________________ PERSON 8. SHARED DISPOSITIVE POWER 4,898 WITH: - ------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,898 - ------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] N/A - ------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0% - ------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON* BK - ------------------------------------------------------------------------------- CUSIP No. 955306-105 - ------------------------------------------------------------------------------ Item 1(a). Name of Issuer: West Pharmaceutical Services Inc. - ------------------------------------------------------------------------------ Item 1(b). Address of Issuer's Principal Executive Offices: 101 Gordon Drive Lionville, PA 19341-0645 - ----------------------------------------------------------------------------- Item 2(a). Name of Person Filing: Wilmington Trust Corporation, Wilmington Trust Company and Wilmington Trust FSB - ------------------------------------------------------------------------------ Item 2(b). Address of Principal Business Office, or if None, Residence: 1100 North Market Street Wilmington, DE 19890 - ------------------------------------------------------------------------------ Item 2(c). Citizenship: Wilmington Trust Corporation is a Delaware corporation; Wilmington Trust Company is a Delaware banking corporation; and Wilmington Trust FSB is a Federal Savings Bank. - ------------------------------------------------------------------------------ Item 2(d). Title of Class of Securities: Common Stock - ------------------------------------------------------------------------------ Item 2(e). CUSIP Number: 955306-105 - ------------------------------------------------------------------------------ Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [_] Broker or dealer registered under Section 15 of the Exchange Act. (b) [X] Bank as defined in Section 3(a)(6) of the Exchange Act. CUSIP No. 955306-105 Wilmington Trust Company and Wilmington FSB are each Banks and are each direct, wholly- owned subsidiaries of Wilmington Trust Corporation. (c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) [_] Investment company registered under Section 8 of the Investment Company Act. (e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); Wilmington Trust Corporation is a Parent Holding Company. (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) [_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) [X] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). Wilmington Trust Corporation, Wilmington Trust Company and Wilmington Trust FSB are a Group. Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: Wilmington Trust Corporation: 889,918 shares Wilmington Trust Company: 885,020 shares Wilmington Trust FSB: 4,898 shares (b) Percent of class: Wilmington Trust Corporation: 6.1% CUSIP No. 955306-105 Wilmington Trust Company: 6.1% Wilmington Trust FSB: 0% (c) Number of shares as to which Wilmington Trust Corporation has: (i) Sole power to vote or to direct the vote 439,620 shares (ii) Shared power to vote or to direct the vote 450,298 shares (iii) Sole power to dispose or to direct the disposition of 439,620 shares (iv) Shared power to dispose or to direct the disposition of 450,298 shares Number of shares as to which Wilmington Trust Company has: (i) Sole power to vote or to direct the vote 439,620 shares (ii) Shared power to vote or to direct the vote 445,400 shares (iii) Sole power to dispose or to direct the disposition of 439,620 shares (iv) Shared power to dispose or to direct the disposition of 445,400 shares Number of shares as to which Wilmington Trust FSB has: (i) Sole power to vote or to direct the vote 0 shares (ii) Shared power to vote or to direct the vote 4,898 shares (iii) Sole power to dispose or to direct the disposition of 0 shares (iv) Shared power to dispose or to direct the disposition of 4,898 shares - ------------------------------------------------------------------------------ Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ] - ------------------------------------------------------------------------------ Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Not applicable. - ------------------------------------------------------------------------------ Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Wilmington Trust Company: BK Wilmington Trust FSB: BK CUSIP No. 955306-105 - ------------------------------------------------------------------------------ Item 8. Identification and Classification of Members of the Group. Wilmington Trust Corporation: HC Wilmington Trust Company: BK Wilmington Trust FSB: BK - ------------------------------------------------------------------------------ Item 9. Notice of Dissolution of Group. Not applicable. - ------------------------------------------------------------------------------ Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 3, 2004 By: s/Michael A. DiGregorio ------------------------- Michael A. DiGregorio Senior Vice President WILMINGTON TRUST CORPORATION WILMINGTON TRUST COMPANY WILMINGTON TRUST FSB Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent. Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). WILMINGTON TRUST COMPANY 1100 North Market Street Wilmington, Delaware 19890 February 3, 2004 United States Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Dear Gentlemen/Ladies: Pursuant to Rule 13d-1(b)(1) under the Securities Exchange Act of 1934, as amended, we are filing herewith in electronic format a Schedule 13-G reflecting beneficial ownership as of December 31, 2003 by Wilmington Trust Company, with respect to the following issuer and security: West Pharmaceutical Services Common Stock Please contact me if there are any questions regarding this filing. Sincerely, /s/ Sharon L. Corbett - ---------------------------- Sharon L. Corbett Assistant Vice President and Fiduciary Compliance Counsel Telephone Number (302) 651-8378 -----END PRIVACY-ENHANCED MESSAGE-----